相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Regulation of fibroblast growth factor-23 in chronic kidney disease
Per-Anton Westerberg et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2007)
Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men
Y. Nishida et al.
KIDNEY INTERNATIONAL (2006)
Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men
Diana M. Antoniucci et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men:: MrOS Sweden
D Mellström et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice
F Perwad et al.
ENDOCRINOLOGY (2005)
Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease
O Gutierrez et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
A novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis
T Larsson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients
S Nakanishi et al.
KIDNEY INTERNATIONAL (2005)
An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia
A Benet-Pagès et al.
HUMAN MOLECULAR GENETICS (2005)
FGF-23 in patients with end-stage renal disease on hemodialysis
Y Imanishi et al.
KIDNEY INTERNATIONAL (2004)
Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency
T Shigematsu et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2004)
Transgenic mice expressing fibroblast growth factor 23 under the control of the α1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis
T Larsson et al.
ENDOCRINOLOGY (2004)
Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders
XY Bai et al.
ENDOCRINOLOGY (2004)
Serum FGF23 levels in normal and disordered phosphorus homeostasis
TJ Weber et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.
KB Jonsson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers
T Larsson et al.
KIDNEY INTERNATIONAL (2003)
Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia
Y Yamazaki et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia
T Shimada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23
KE White et al.
NATURE GENETICS (2000)
分享论文
